StockDuty ← Dashboard Aug 10, 2026 10:27 AM ET
CatalystFDA/Bio

ATyr Pharma Q2 Net Loss Narrows; Cuts Workforce By 60% To Advance Efzofitimod Into Phase 3

ATyr Pharma Q2 Net Loss Narrows; Cuts Workforce By 60% To Advance Efzofitimod Into Phase 3

Sources